Back to top

medical-devices: Archive

Moumi Mondal

CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?

CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.

UNHPositive Net Change CVSPositive Net Change CNCPositive Net Change

Zacks Equity Research

Reasons to Retain Avanos Medical Stock in Your Portfolio Now

AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.

BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change AVNSPositive Net Change

Moumi Mondal

Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds

HOLX lifts its 2025 revenue and EPS outlook on Q3 strength, tariff relief, and growth across Breast Health and GYN Surgical.

BDXPositive Net Change HOLXNegative Net Change QGENPositive Net Change

Zacks Equity Research

Should You Continue to Hold EXAS Stock in Your Portfolio?

Exact Sciences sees growth in Cologuard and Oncotype DX, but rising costs and tough competition weigh on EXAS shares.

MASINegative Net Change PAHCPositive Net Change EXASNegative Net Change NVSTNegative Net Change

Zacks Equity Research

Dentsply Sirona Retains Wellspect Following Strategic Review

XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.

XRAYPositive Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change

Indrajit Bandyopadhyay

Ion Platform Poised for Cost Optimization: A Margin Lever for ISRG?

Intuitive Surgical's Ion platform is driving rapid growth, but cost optimization could be the key to turning it from a margin drag to a margin lever.

JNJNegative Net Change MDTPositive Net Change ISRGPositive Net Change

Zacks Equity Research

Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.

BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change MBOTPositive Net Change

Zacks Equity Research

FONAR's Stock Advances 5% in Three Months: Key Trends Ahead

FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.

FONRNegative Net Change ICCCNegative Net Change UGNegative Net Change

Zacks Equity Research

Lifeward Achieves European Approval for Latest ReWalk Exoskeleton

LFWD secures CE mark for its ReWalk 7 Personal Exoskeleton, unlocking new European sales potential with advanced features.

WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change LFWDPositive Net Change

Zacks Equity Research

ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay

The Illumina Protein Prep rollout boosts multiomics, strengthens disease insights and supports ILMN stock momentum.

ILMNPositive Net Change MASINegative Net Change PAHCPositive Net Change NVSTNegative Net Change

Zacks Equity Research

Best Value Stocks to Buy for September 9th

JXN, EMBC and KT made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 9, 2025.

KTNegative Net Change JXNPositive Net Change EMBCPositive Net Change

Zacks Equity Research

Cardinal Health Expands At-Home Solutions With New Texas Facility

CAH announces the opening of a new distribution center in Texas, which is likely to support its at-Home Solutions business.

BSXPositive Net Change CAHPositive Net Change WSTNegative Net Change MEDPNegative Net Change

Debanjana Dey

Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem

HIMS expands its digital health footprint with global moves, top-tier partnerships and more than 1,500 providers.

AMWLPositive Net Change HIMSNegative Net Change LFMDNegative Net Change

Moumi Mondal

CVS Health Trades Cheaper Than Industry: How to Play the Stock?

CVS' diversified model, digital push and Aetna stabilization highlight a compelling investment story.

UNHPositive Net Change CIPositive Net Change CVSPositive Net Change

Zacks Equity Research

GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System

GE HealthCare's FDA-cleared Revolution Vibe CT promises faster, AI-driven cardiac imaging with improved clarity, boosting efficiency and patient comfort.

BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change GEHCNegative Net Change